1. Home
  2. GRCE vs LGCL Comparison

GRCE vs LGCL Comparison

Compare GRCE & LGCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GRCE
  • LGCL
  • Stock Information
  • Founded
  • GRCE 2002
  • LGCL 2009
  • Country
  • GRCE United States
  • LGCL China
  • Employees
  • GRCE N/A
  • LGCL N/A
  • Industry
  • GRCE
  • LGCL
  • Sector
  • GRCE
  • LGCL
  • Exchange
  • GRCE NYSE
  • LGCL NYSE
  • Market Cap
  • GRCE 42.1M
  • LGCL 47.7M
  • IPO Year
  • GRCE N/A
  • LGCL 2024
  • Fundamental
  • Price
  • GRCE $2.94
  • LGCL $0.96
  • Analyst Decision
  • GRCE Strong Buy
  • LGCL
  • Analyst Count
  • GRCE 1
  • LGCL 0
  • Target Price
  • GRCE $12.00
  • LGCL N/A
  • AVG Volume (30 Days)
  • GRCE 53.8K
  • LGCL 832.5K
  • Earning Date
  • GRCE 06-23-2025
  • LGCL 01-01-0001
  • Dividend Yield
  • GRCE N/A
  • LGCL N/A
  • EPS Growth
  • GRCE N/A
  • LGCL N/A
  • EPS
  • GRCE N/A
  • LGCL 0.07
  • Revenue
  • GRCE N/A
  • LGCL $145,690,427.00
  • Revenue This Year
  • GRCE N/A
  • LGCL N/A
  • Revenue Next Year
  • GRCE N/A
  • LGCL N/A
  • P/E Ratio
  • GRCE N/A
  • LGCL $18.10
  • Revenue Growth
  • GRCE N/A
  • LGCL N/A
  • 52 Week Low
  • GRCE $1.75
  • LGCL $0.28
  • 52 Week High
  • GRCE $4.97
  • LGCL $3.31
  • Technical
  • Relative Strength Index (RSI)
  • GRCE N/A
  • LGCL N/A
  • Support Level
  • GRCE N/A
  • LGCL N/A
  • Resistance Level
  • GRCE N/A
  • LGCL N/A
  • Average True Range (ATR)
  • GRCE 0.00
  • LGCL 0.00
  • MACD
  • GRCE 0.00
  • LGCL 0.00
  • Stochastic Oscillator
  • GRCE 0.00
  • LGCL 0.00

About GRCE GRACE THERAPEUTICS INC

Grace Therapeutics Inc is a late-stage specialty pharma company with drug delivery technologies and drug candidates addressing rare and orphan diseases. The company's lead drug candidate, GTx-104, is a novel injectable formulation of nimodipine for the treatment of a rare disease, aneurysmal subarachnoid hemorrhage.

About LGCL LUCAS GC LIMITED

Lucas GC Ltd is a technology-driven online agent-centric human capital management service provider targeting professionals based on PaaS in China. Its business segments consist of recruitment services, outsourcing services, and other services, which include information technology services and training services.

Share on Social Networks: